Filing Flows › Neuronetics (STIM) › Q2 2026 › vs Q1 2026
Neuronetics (STIM) Q2 2026 vs Q1 2026 (quarter over quarter)
Neuronetics's revenue rose $7.1M (+21%) from $34.5M in Q1 2026 to $41.6M in Q2 2026. The biggest changes: Service +$5.4M (+25%); NeuroStar +$1.8M (+14%).
Neuronetics, Q2 2026: revenue $41.6M (+9% year over year), operating margin -3.6%, net loss $3.5M, operating cash flow −$1.0M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Service | $26.9M | $21.5M | $5.4M | +25% |
| NeuroStar | $14.7M | $12.9M | $1.8M | +14% |
| Revenue | $41.6M | $34.5M | $7.1M | +21% |
| Net loss | $3.5M | $10.8M | −$7.3M | -68% |
| Costs & expenses | $45.0M | $45.2M | −$202K | -0.4% |
| Operating costs | $43.1M | $43.4M | −$380K | -0.9% |
| Interest & other, net | $2.0M | $1.8M | $178K | +10% |
| Cost of revenue | $20.3M | $18.3M | $2.0M | +11% |
| Research & development | $1.3M | $1.4M | −$28K | -2% |
| Sales & marketing | $10.0M | $10.7M | −$753K | -7% |
| General & admin | $11.4M | $13.0M | −$1.6M | -13% |
| Operating cash sources | $3.5M | $10.8M | −$7.3M | -68% |
| Depreciation & amortization | $729K | $745K | −$16K | -2% |
| Share-based compensation | $688K | $1.7M | −$989K | -59% |
| Working capital & other | $1.0M | −$1.1M | $2.1M | — |
| Cash used in operations | $1.0M | $9.4M | −$8.4M | -89% |
| Net loss absorbed | $3.5M | $10.8M | −$7.3M | -68% |
Questions
How much did Neuronetics's revenue grow quarter over quarter in Q2 2026?
Neuronetics's revenue rose $7.1M (+21%) from $34.5M in Q1 2026 to $41.6M in Q2 2026.
What drove Neuronetics's revenue change in Q2 2026?
Service +$5.4M (+25%); NeuroStar +$1.8M (+14%).